This entry was posted on Wednesday, December 2nd, 2009 at 9:19 am and is filed under FYI. You can leave a response, or trackback from your own site.
We chose to forgo the use of vaccine additives that could have boosted effectiveness and might have helped us stretch our limited supply of vaccine raw material over more shots. Instead, we are compelled to rely on old, unpredictable manufacturing technology because we have not used more modern tools to develop the necessary capacities.
December 2nd, 2009 at 9:35 am
If you are telling me that government is the problem, I have no trouble believing you.
December 2nd, 2009 at 9:50 am
This piece is by Scott Gottlieb, who is always very good on these types of issues.
December 2nd, 2009 at 10:29 am
From what I have read the vaccine is not going where the need is greatest. Isn’t that what markets are supposed to do? So can we conclude, a priori, that there is no real market at work here?
December 23rd, 2009 at 12:18 am
One of my sisters got infected with H1N1 or more commonly known as Swine Flu. Fortunately, she did not have very high fever and she was able to recover fast .
*
January 1st, 2010 at 11:55 pm
My brother got infected with H1N1 or Swine Flu in Mexico. He got a mild fever and luckily he did not die.
January 4th, 2010 at 10:12 pm
If you look at the pandemic of 1977, when H1N1 or Swine Flu re-emerged after a 20 year absence, there is no shift in age-related mortality pattern. The 1977 “pandemic” is, of course, not considered a true pandemic by experts today, for reasons that are not entierely consistent. It certainly was an antigenic shift and not an antigenic drift. As far as I have been able to follow the current events, the most significant factor seems to have been that most people, who were severely affected, were people with other medical conditions.